IPSNEWS

RAUpdate: Creation of the CENAFyT and its impact on the health sector.

RAUpdate: Creation of the CENAFyT and its impact on the health sector.

On March 9, 2026, COFEPRIS officially announced the creation of the National Center for Pharmacovigilance and Technovigilance (CENAFYT). This body emerges not as an isolated entity, but as the strategic evolution of the former National Pharmacovigilance Center (CNFV), following the legal modifications made to the General Health Law at the beginning of 2026.

Read More
Ingredient regulatory framework for dietary supplements in Mexico: A compliance guide
IPS, Dietary Supplements Mariel Antonio IPS, Dietary Supplements Mariel Antonio

Ingredient regulatory framework for dietary supplements in Mexico: A compliance guide

This article details the legal and sanitary framework governing permitted and prohibited ingredients in the formulation of dietary supplements in Mexico. It addresses questions regarding the technical viability of formulas, limits on additives, vitamins, minerals, and botanical extracts to avoid sanctions, customs seizures, or product redesigns.

Read More
COFEPRIS Electronic Notification: Digitalization and deadline optimization

COFEPRIS Electronic Notification: Digitalization and deadline optimization

The Federal Commission for the Protection against Sanitary Risks (COFEPRIS) has formalized the use of email as an official channel for notification and requirements. This mechanism aims to streamline response times, reduce backlogs, and provide legal certainty to regulated entities by allowing digital tracking of administrative procedures.

Read More
Víctor Hugo Borja: Management, challenges, and future
COFEPRIS Mariel Antonio COFEPRIS Mariel Antonio

Víctor Hugo Borja: Management, challenges, and future

The Federal Commission for the Protection against Sanitary Risks (COFEPRIS) has entered a new stage under the leadership of Dr. Víctor Hugo Borja Aburto, who took office on January 1, 2026. His administration is part of the consolidation of the universal health system and the execution of the industrial policy established in the Plan México.

Read More
Dietary Supplements, Herbal Remedies, and Medicines: Key differences in their regulation.
IPS, Dietary Supplements IPS IPS, Dietary Supplements IPS

Dietary Supplements, Herbal Remedies, and Medicines: Key differences in their regulation.

In the Mexican regulatory landscape, the classification of products intended for health or well-being is fundamental. In the market, we can find options such as dietary supplements, herbal remedies, and medicines, all of which possess specific characteristics, a defined purpose of use, and, most importantly, a clearly differentiated regulatory framework.

Read More